Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 0 | 100,827 | 85,695 | 80,800 |
| Gross Profit | N/A | N/A | 100,827 | 85,695 | 80,800 |
| Operating Expenses | 0 | 0 | 34,384 | 34,856 | 32,037 |
| Operating Income | N/A | N/A | 66,443 | 50,839 | 48,763 |
| Interest Expense | 0 | 0 | 11,458 | 11,114 | 11,172 |
| Other Income | 0 | 0 | -152 | 74 | -410 |
| Pre-tax Income | 0 | 0 | 54,833 | 39,799 | 37,181 |
| Income Tax | N/A | N/A | 3,678 | 1,856 | 2,504 |
| Net Income Continuous | N/A | N/A | 51,155 | 37,943 | 34,677 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 1,063 |
| Net Income | $N/A | $N/A | $51,155 | $37,943 | $35,740 |
| EPS Basic Total Ops | 0.09 | -7.97 | 2.82 | 2.07 | 1.94 |
| EPS Basic Continuous Ops | N/A | N/A | 2.82 | 2.07 | 1.88 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.06 |
| EPS Diluted Total Ops | 0.08 | -7.97 | 2.79 | 2.04 | 1.91 |
| EPS Diluted Continuous Ops | N/A | N/A | 2.79 | 2.04 | 1.85 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.06 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | 2.79 | 2.04 | 1.85 |
| EBITDA(a) | $N/A | $N/A | $100,149 | $81,117 | $78,344 |